BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 33603224)

  • 1. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer.
    Thrift AP
    Nat Rev Gastroenterol Hepatol; 2021 Jun; 18(6):432-443. PubMed ID: 33603224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrett oesophagus and adenocarcinoma: an overview of epidemiologic, conceptual and clinical issues.
    van Sandick JW; van Lanschot JJ; Tytgat GN; Offerhaus GJ; Obertop H
    Scand J Gastroenterol Suppl; 2001; (234):51-60. PubMed ID: 11768562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barrett's oesophagus: Current controversies.
    Amadi C; Gatenby P
    World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barrett's oesophagus: epidemiology, cancer risk and implications for management.
    de Jonge PJ; van Blankenstein M; Grady WM; Kuipers EJ
    Gut; 2014 Jan; 63(1):191-202. PubMed ID: 24092861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The path(ology) from reflux oesophagitis to Barrett oesophagus to oesophageal adenocarcinoma.
    Salimian KJ; Birkness-Gartman J; Waters KM
    Pathology; 2022 Mar; 54(2):147-156. PubMed ID: 34711413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.
    Pohl H; Pech O; Arash H; Stolte M; Manner H; May A; Kraywinkel K; Sonnenberg A; Ell C
    Gut; 2016 Feb; 65(2):196-201. PubMed ID: 26113177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased detection rates of Barrett's oesophagus without rise in incidence of oesophageal adenocarcinoma.
    Hurschler D; Borovicka J; Neuweiler J; Oehlschlegel C; Sagmeister M; Meyenberger C; Schmid U
    Swiss Med Wkly; 2003 Sep; 133(37-38):507-14. PubMed ID: 14652799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota.
    Conio M; Cameron AJ; Romero Y; Branch CD; Schleck CD; Burgart LJ; Zinsmeister AR; Melton LJ; Locke GR
    Gut; 2001 Mar; 48(3):304-9. PubMed ID: 11171817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of Barrett oesophagus: role of endoscopic and histological predictors.
    Anaparthy R; Sharma P
    Nat Rev Gastroenterol Hepatol; 2014 Sep; 11(9):525-34. PubMed ID: 24860927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and risk factors for oesophageal adenocarcinoma.
    Lepage C; Drouillard A; Jouve JL; Faivre J
    Dig Liver Dis; 2013 Aug; 45(8):625-9. PubMed ID: 23453359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To investigate outcomes in endoscopic management of early oesophageal adenocarcinoma in Barrett oesophagus: experience at three Australian tertiary centres.
    Pateria P; Chong A; Muwanwella N; Siah C; Kumarasinghe P; Raftopoulos S
    Intern Med J; 2022 Apr; 52(4):633-639. PubMed ID: 33073906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance.
    Rana PS; Johnston DA
    Dis Esophagus; 2000; 13(1):28-31. PubMed ID: 11005328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esophageal Adenocarcinoma and Its Rare Association with Barrett's Esophagus in Henan, China.
    Liu S; Dai JY; Yao L; Li X; Reid B; Self S; Ma J; Chang Y; Feng S; Tapsoba Jde D; Sun X; Sun X
    PLoS One; 2014; 9(10):e110348. PubMed ID: 25333822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and populations at risk: selection of patients for screening for Barrett's oesophagus.
    Rubenstein JH; Thrift AP
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):41-50. PubMed ID: 25743455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
    Quera R; O'Sullivan K; Quigley EM
    Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goblet Cell Ratio in Combination with Differentiation and Stem Cell Markers in Barrett Esophagus Allow Distinction of Patients with and without Esophageal Adenocarcinoma.
    Schellnegger R; Quante A; Rospleszcz S; Schernhammer M; Höhl B; Tobiasch M; Pastula A; Brandtner A; Abrams JA; Strauch K; Schmid RM; Vieth M; Wang TC; Quante M
    Cancer Prev Res (Phila); 2017 Jan; 10(1):55-66. PubMed ID: 27807078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: Barrett's oesophagus and carcinoma in Japan.
    Hongo M
    Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():50-4. PubMed ID: 15575874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barrett oesophagus.
    Peters Y; Al-Kaabi A; Shaheen NJ; Chak A; Blum A; Souza RF; Di Pietro M; Iyer PG; Pech O; Fitzgerald RC; Siersema PD
    Nat Rev Dis Primers; 2019 May; 5(1):35. PubMed ID: 31123267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms and pathophysiology of Barrett oesophagus.
    Souza RF; Spechler SJ
    Nat Rev Gastroenterol Hepatol; 2022 Sep; 19(9):605-620. PubMed ID: 35672395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant Barrett's oesophagus.
    Li H
    Eur J Cancer Prev; 1993 Jan; 2(1):47-52. PubMed ID: 8428176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.